Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels.
about
Stem/progenitor cells in endogenous repairing responses: new toolbox for the treatment of acute lung injuryObesity, inflammation, and lung injury (OILI): the good.Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells?Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep.Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injuryIn Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts.Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model.The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells.Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival.Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases.The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
P2860
Q28079971-CF56C8A0-EEE6-4E17-A1F0-F142EF194366Q30363313-CEAEB403-4715-458B-AB30-4F54164FFCBBQ30791618-CF6CDE1B-0ACB-4717-B531-2FF9DB0F6FB0Q33746517-F9FC9677-B707-4C95-93E4-ABC75FD36FD4Q33770974-C9F86266-67E4-4C00-94F4-E0205133DEA0Q35809674-F58F2032-5E76-46B0-B72F-4386D7655D59Q36067836-8EDE2C9C-89AF-4C5A-B110-44477960EF1EQ37708086-D4A1EC15-8D35-45A5-AE94-E2174814F421Q38733865-8ECCD3B1-CC4A-45E6-AB29-0CDCFE6581F9Q38767642-C0A1C53C-AB1A-4DC1-8A0F-EF5E53059C6BQ39171316-75F08872-407B-4A7F-9F82-310C104614CBQ40965563-3CC3BDEB-BF18-4926-B572-628A7D367DD9Q41657670-1FBBC13F-A0F5-4AF3-8869-491DE450A55DQ50347339-C0A05BFD-36E0-44EF-84B4-DCB746750A23Q58694877-CEE05635-1162-4C50-B117-F45338363535
P2860
Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Activation of human mesenchyma ...... kin (IL)-10 and IL-1RN levels.
@en
Activation of human mesenchyma ...... jury by increasing interleukin
@nl
type
label
Activation of human mesenchyma ...... kin (IL)-10 and IL-1RN levels.
@en
Activation of human mesenchyma ...... jury by increasing interleukin
@nl
prefLabel
Activation of human mesenchyma ...... kin (IL)-10 and IL-1RN levels.
@en
Activation of human mesenchyma ...... jury by increasing interleukin
@nl
P2093
P2860
P356
P1476
Activation of human mesenchyma ...... kin (IL)-10 and IL-1RN levels.
@en
P2093
Albert D Donnenberg
Bryan J McVerry
Bryon M Ellis
Ernest M Meyer
Joseph D Sciurba
Luai Huleihel
Martha L Bustos
Mauricio Rojas
Vera S Donnenberg
P2860
P304
P356
10.5966/SCTM.2013-0033
P577
2013-10-02T00:00:00Z